iifl-logo

Gland Pharma Ltd Historical Data

1,952.8
(-0.21%)
Oct 9, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Gland Pharma Ltd Historical Data

09/09/2025calendar-icon
09/10/2025calendar-icon
Date
Open(₹)
High(₹)
Low(₹)
Close(₹)
No. Of Trades(₹)
Total Turnover(₹)
Deliverable Quantity(₹)

09-Sep-2025

1,878

1,9301,871.51,92115,73282,31,83,576.43,67,978

10-Sep-2025

1,931

1,964.31,8871,902.515,19025,52,51,860.868,412

11-Sep-2025

1,912.5

1,985.81,902.71,965.836,67961,87,20,117.31,51,422

12-Sep-2025

1,975.6

2,0271,9522,021.219,14248,63,75,684.31,31,682

15-Sep-2025

2,015

2,0461,9962,017.218,41445,96,12,2891,54,850

16-Sep-2025

2,015.1

2,049.82,008.62,021.821,16138,87,34,739.71,19,038

17-Sep-2025

2,027.3

2,0451,9711,986.922,07943,38,05,799.91,38,045

18-Sep-2025

1,987

2,0251,9872,016.518,77554,43,02,7411,78,264

19-Sep-2025

2,010.2

2,034.42,007.92,022.822,34035,64,24,515.11,18,196

22-Sep-2025

2,025

2,0251,991.12,014.821,48434,81,39,281.91,26,041

23-Sep-2025

2,023.8

2,0551,988.22,017.217,71426,70,61,411.780,521

24-Sep-2025

2,020

2,0281,9701,977.819,10917,04,54,449.349,911

25-Sep-2025

1,991

2,007.61,968.11,972.815,82320,28,95,280.657,764

26-Sep-2025

1,900.1

1,9891,8801,958.151,2231,14,89,60,7492,41,447

29-Sep-2025

1,950

2,0741,920.31,99876,5462,05,24,55,050.96,30,154

30-Sep-2025

2,003.3

2,040.91,978.11,991.623,01638,92,06,422.81,29,958

01-Oct-2025

1,992

2,026.11,9741,981.616,56919,37,65,931.750,212

03-Oct-2025

1,960.1

2,0001,9451,951.417,21427,29,69,725.377,851

06-Oct-2025

1,953

1,957.51,9261,939.611,47326,00,75,975.290,306

07-Oct-2025

1,940.5

1,9501,924.31,940.38,7419,01,16,669.624,226

08-Oct-2025

1,937.8

1,964.91,9251,9578,79414,05,79,130.340,903

09-Oct-2025

1,955

1,969.61,937.11,952.814,36934,05,60,073.71,37,188

Gland Pharma: Related NEWS

Top Stocks for Today - 14th July 2025

Here are some of the stocks that may see significant price movement today: Avenue Supermarts, BEML, Gland Pharma, etc.

14 Jul 2025|06:30 AM
Read More
Gland Pharma Gets USFDA Clearance for Visakhapatnam Facility

The receipt of the EIR marks the formal closure of the US health regulator’s pre-approval inspection, which was conducted between February 19 and February 25, 2025.

25 Jun 2025|12:07 PM
Read More
Top Stocks for Today - 5th June 2025

Here are some of the stocks that may see significant price movement today: Hindustan Aeronautics, Gland Pharma, REC, etc.

5 Jun 2025|07:53 AM
Read More
Gland Pharma gets USFDA approval for blood pressure drug

Gland Pharma also established that its version is bioequivalent and therapeutically equivalent to the reference listed drug.

4 Jun 2025|03:34 PM
Read More
Gland Pharma Q4 Net Profit Declines 3.1% to ₹186.5 Crore; Revenue Down 7.3% YoY

Gland Pharma net profit was at ₹186.5 crore as against ₹192.4 crore in the year-ago quarter of FY24.

22 May 2025|08:49 AM
Read More
Gland Pharma Gets USFDA Nod for Glaucoma Drug

Gland Pharma has secured exclusive rights as the first-to-file sponsor of this generic product. This makes it eligible for 180 days of marketing exclusivity in the US

30 Apr 2025|03:40 PM
Read More
USFDA Issues Three Observations to Gland Pharma's Visakhapatnam Facility

The FDA conducted the pre-approval inspection (PAI) from Feb. 19, 2025, to Feb. 25, 2025, as part of the regulatory process for sterile APIs.

26 Feb 2025|12:22 PM
Read More
Top Stocks for Today - 4th February 2025

Here are some of the stocks that may see significant price movement today: Tata Chemicals, Power Grid, Welspun Enterprises, etc.

4 Feb 2025|07:20 AM
Read More
Gland Pharma Q3 Profit Rises 6.7% YoY

EBITDA (Earnings Before Interest, Tax, Depreciation, and Amortization) increased by 1% YoY to ₹360 crore, compared to ₹356.4 crore in the previous year.

3 Feb 2025|07:43 PM
Read More
Mankind Pharma inks pact to commercialise Sintilimab in India

Sintilimab is marketed in China as TYVYT (sintilimab injectable) and was co-developed by Innovent and Eli Lilly.

27 Dec 2024|09:09 AM
Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.